Popular Articles

Oct 03, 2009
Successful Product Manager's Handbook
By Pharmaceutical Executive Editors
The most imporant thing to remember when planning a global clinical trial is very basic and almost always overlooked
Oct 03, 2009
Successful Product Manager's Handbook
By Pharmaceutical Executive Editors
What you need to know in order to budget right and for less money
Aug 01, 2009
Pharmaceutical Executive
With the biotech industry reeling from the recession, big drugmakers hold all the cards when it comes to making deals, but picking a winner is still a gamble. Here are 10 to place stakes on.
Aug 01, 2009
Pharmaceutical Executive
The Belgian drugmaker is pursuing a sale, inking deals, issuing debt, and launching a power drug for Parkinson's—all at once.
Jul 07, 2009
Agency Confidential
Agency Insider Mark Chattaway infiltrates the world of online social media. His consensus: Advertising on social networks is iffy at best
Jul 01, 2009
Pharmaceutical Executive
Chris Viehbacher's first fast and furious six months at the top of Sanofi-Aventis have heads spinning...and rolling.
Jun 03, 2009
Agency Confidential
Pharma friendless on Facebook | DTC ad spending flat | Rate of healthcare marketing and advertising falls | Consumers chose food over meds | Some see light at tunnel's end
Apr 22, 2009
Companies are fighting for strong relationships with key opinion leaders—and Genentech is winning, hands down.
Apr 15, 2009
Pharmaceutical Executive
By Pharmaceutical Executive Editors
In an effort to realign its sales division to reflect the current pharma environment—smaller, faster, better—Johnson & Johnson is trimming its sales force.
Apr 08, 2009
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Just two months after the purchase of Wyeth, Pfizer breaks its research division into two—one for large molecules and vaccines, and another for small molecules—with Wyeth and Pfizer execs at the helms.
native1_300x100
lorem ipsum